Trade Bristol Myers BMY

BristolMyers live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Noah Lee 2025 Sep 25, 10:10

PIMCO Bets on UK Inflation Decline, Anticipates Aggressive BOE Rate Cuts

Ava Grace 2025 Sep 25, 10:10

FINRA Rule Change: Potential Easing of Day Trading Requirements

Liam James 2025 Sep 25, 10:10

US Market Resurgence: Global Asset Allocation Shifts Amidst AI Boom and Rate Cut Expectations

Ghko B 2025 Sep 24, 16:00

RKLB Stock Dropped 7% Today: What’s Happening to Rocket Lab?

stocks
Ghko B 2025 Sep 24, 16:00

How High Could These Top Cryptos Go in 2025: Pi Network, XRP, SOL, BTC

crypto
Ghko B 2025 Sep 23, 16:00

Fintech Stocks to Watch Now: Nu Holdings (NU) Stock, SOFI Stock

stocks
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Ava Grace 2025 Sep 25, 09:20

White House Budget Office Directs Federal Agencies to Prepare for Mass Layoff Plans Amid Shutdown Fears

Liam James 2025 Sep 25, 09:20

Inflation Fears Grow: Is the US Economy Heading Towards Stagflation?

Sophia Claire 2025 Sep 25, 06:20

DoubleLine Capital Flags Concerns Over US Economic Data Quality, Turns to Alternative Sources

Liam James 2025 Sep 25, 04:20

Trump Shifts Ukraine Strategy: Pressure on Europe to Step Up

Sophia Claire 2025 Sep 25, 02:20

Trump Pledges to Arab Leaders He Won't Allow Israel to Annex West Bank

Ava Grace 2025 Sep 25, 01:20

Kremlin Dismisses Trump's Ukraine Stance Shift, Demands 'Real Information'

Emma Rose 2025 Sep 24, 15:20

US Treasury Chief Criticizes Powell's Rate Cut Stance, Praises New Fed Member

Noah Lee 2025 Sep 24, 11:21

Trump Approval Rating Dips Amid Economic Concerns: Reuters/Ipsos Poll

Info

Spread

0.28

Spread (%)

0.6355 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

89884844032

Shares Outstanding

2035435838

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-10-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.0552

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 24, 16:00

How to Trade VOO ETF CFDs in the Middle East: AvaTrade, Saxo and More

CFD Trading ETFs Stocks
Frances Wang 2025 Sep 24, 16:00

XAU/USD Holds over $3740: How to Trade Gold CFDs in Saudi Arabia?

Commodities CFD Trading
Frances Wang 2025 Sep 24, 16:00

Stocks to Watch in Saudi Arabia: How to Trade Stock CFDs with markets.com?

Stocks
Trustpilot